TP53 and thyroid gland carcinoma: The prognosis is similar in UTC with and without p53 mutations, a finding that supports the existence of alternative pathways to achieve a similar end result; WNT pathway and CDK/CDKI molecules, which were found altered in thyroid cancer cell lines and/or primary tumours [54, 55] appear to be good candidates (see below).